Despite some disappointments, the market for protein arrays is following a healthy growth curve that will lead to an approximately $600 million market by 2008 if current trends continue and application-focused work accelerates, according to Steven Bodovitz, principal consultant for Select Biosciences, a firm that tracks life sciences market trends. “The demand is there — it’s just a matter of getting these technologies to work well,” he told ProteoMonitor. “If it works as advertised, there’s definitely a market for it.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.